News

BioSig’s PURE EP™ Platform Debuts New Automated Features in First Patient Cases

Latest Software Release Supports Electrophysiologists with Visualizing Heart Patterns Difficult to Recognize with the Naked EyeWestport, CT, Aug. 22, 2023…

1 year ago

SeaStar Medical to Hold Business Update Conference Call Today at 4:00 p.m. Eastern Time

DENVER, Aug. 22, 2023 (GLOBE NEWSWIRE) -- SeaStar Medical Holding Corporation (Nasdaq: ICU) (“SeaStar Medical” or the “Company”), a medical…

1 year ago

Longeveron Rights Offering Subscription Period Begins

MIAMI, Aug. 22, 2023 (GLOBE NEWSWIRE) -- Longeveron Inc. (NASDAQ: LGVN NASDAQ: LGVNR) (“Longeveron” or “Company”), a clinical stage biotechnology…

1 year ago

PROCEPT BioRobotics® Announces First Commercial Aquablation Therapy Procedures in Japan

REDWOOD CITY, Calif., Aug. 22, 2023 (GLOBE NEWSWIRE) -- PROCEPT BioRobotics® Corporation (NASDAQ: PRCT) (“PROCEPT BioRobotics”), a global leader in…

1 year ago

Cabaletta Bio and WuXi Advanced Therapies Announce Expansion of GMP Manufacturing Agreement to Include CABA-201

– Agreement expansion facilitates preparation for commercial readiness for CABA-201, enabling treatment of patients in multiple planned clinical trials with…

1 year ago

Randy Jouben Receives 2023 Workers’ Comp Risk Management Award for Excellence

The award recognizes multiple innovative programs for Fairfax County, VirginiaFT. WORTH – Texas, Aug. 22, 2023 (GLOBE NEWSWIRE) -- CorVel…

1 year ago

60 Degrees Pharmaceuticals Receives Additional U.S. Patent Covering Tafenoquine for Prevention of Plasmodium Falciparum Malaria

60P was awarded additional U.S. patent protection to further solidify its exclusive rights through 2035 for tafenoquine for prevention of…

1 year ago

Vincerx Pharma Announces FDA Clearance of IND for VIP943

Phase 1 trial expected to begin in early Q4 2023 VIP943 is Vincerx’ first candidate from next-generation ADC platform and…

1 year ago

Matinas BioPharma Announces Publication of Results from the Phase 2 EnACT Clinical Trial of MAT2203 in the IDSA Journal Clinical Infectious Diseases

BEDMINSTER, N.J., Aug. 22, 2023 (GLOBE NEWSWIRE) -- Matinas BioPharma (NYSE American: MTNB), a clinical-stage biopharmaceutical company focused on delivering…

1 year ago

Kane Biotech to Release Second Quarter 2023 Financial Results on Aug 29, 2023 – Conference Call to Follow

WINNIPEG, Manitoba, Aug. 22, 2023 (GLOBE NEWSWIRE) -- Kane Biotech Inc. (TSX- V:KNE; OTCQB:KNBIF) (the “Company” or “Kane Biotech”), a…

1 year ago